Paul Claydon is a partner in Covington’s London office. He has more than 25 years’ experience in advising clients on mergers and acquisitions, IPOs and other securities issues, as well as corporate finance, private equity and venture capital transactions. Paul Claydon’s practice covers a wide range of industries; he has particular expertise in advising on deals in the life sciences and technology sectors. His clients include corporates, private equity funds and investment banks.
47
China’s National Development & Reform Commission (“NDRC”) announced this week that it has fined two domestic pharmaceutical companies for monopolizing bulk sales of promethazine hydrochloride in violation of the country’s Anti-Monopoly Law (“AML”). The decision, NDRC’s first AML action in the (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK